Incyte CorpNASDAQ:INCY
- LAST PRICE57.1000
- TODAY'S CHANGE (%)0.2400 (0.4221%)
- Bid / Lots56.0500/ 2
- Ask / Lots57.1000/ 1
- Open / Previous Close56.8300 / 56.8600
- Day Range
- 52 Week Range
- Volume1,618,342
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | INCY |
|---|---|---|
| 09:32 ET | 24969 | 56.82 |
| 09:34 ET | 1195 | 56.73 |
| 09:36 ET | 12133 | 56.54 |
| 09:38 ET | 2700 | 56.46 |
| 09:39 ET | 4937 | 56.55 |
| 09:41 ET | 3237 | 56.6 |
| 09:43 ET | 1000 | 56.5741 |
| 09:45 ET | 3878 | 56.57 |
| 09:48 ET | 1635 | 56.62 |
| 09:50 ET | 400 | 56.62 |
| 09:52 ET | 1033 | 56.58 |
| 09:54 ET | 541 | 56.62 |
| 09:56 ET | 627 | 56.63 |
| 09:57 ET | 500 | 56.63 |
| 09:59 ET | 2137 | 56.61 |
| 10:01 ET | 1600 | 56.63 |
| 10:03 ET | 1400 | 56.585 |
| 10:06 ET | 2615 | 56.63 |
| 10:08 ET | 1475 | 56.69 |
| 10:10 ET | 3445 | 56.7 |
| 10:12 ET | 957 | 56.71 |
| 10:14 ET | 1600 | 56.715 |
| 10:15 ET | 5868 | 56.77 |
| 10:17 ET | 4467 | 56.725 |
| 10:19 ET | 13763 | 56.73 |
| 10:21 ET | 1036 | 56.74 |
| 10:24 ET | 2005 | 56.665 |
| 10:26 ET | 1665 | 56.72 |
| 10:28 ET | 1629 | 56.74 |
| 10:30 ET | 1922 | 56.72 |
| 10:32 ET | 900 | 56.75 |
| 10:33 ET | 3043 | 56.75 |
| 10:35 ET | 1500 | 56.79 |
| 10:37 ET | 4179 | 56.82 |
| 10:39 ET | 3159 | 56.83 |
| 10:42 ET | 1600 | 56.77 |
| 10:44 ET | 2800 | 56.7 |
| 10:46 ET | 1100 | 56.63 |
| 10:48 ET | 6176 | 56.7 |
| 10:50 ET | 1790 | 56.72 |
| 10:51 ET | 3645 | 56.78 |
| 10:53 ET | 4381 | 56.76 |
| 10:55 ET | 2649 | 56.78 |
| 10:57 ET | 1095 | 56.82 |
| 11:00 ET | 11936 | 56.8 |
| 11:02 ET | 4308 | 56.805 |
| 11:04 ET | 3161 | 56.73 |
| 11:06 ET | 4017 | 56.79 |
| 11:08 ET | 2722 | 56.8 |
| 11:09 ET | 3926 | 56.79 |
| 11:11 ET | 400 | 56.78 |
| 11:13 ET | 1075 | 56.8 |
| 11:15 ET | 1985 | 56.84 |
| 11:18 ET | 1538 | 56.84 |
| 11:20 ET | 2015 | 56.8 |
| 11:22 ET | 1570 | 56.77 |
| 11:24 ET | 1300 | 56.78 |
| 11:26 ET | 1100 | 56.76 |
| 11:27 ET | 2700 | 56.74 |
| 11:29 ET | 2377 | 56.77 |
| 11:31 ET | 900 | 56.82 |
| 11:33 ET | 4313 | 56.759 |
| 11:36 ET | 900 | 56.79 |
| 11:38 ET | 1320 | 56.79 |
| 11:40 ET | 2716 | 56.79 |
| 11:42 ET | 3698 | 56.74 |
| 11:44 ET | 3394 | 56.79 |
| 11:45 ET | 3002 | 56.845 |
| 11:47 ET | 3791 | 56.86 |
| 11:49 ET | 2831 | 56.855 |
| 11:51 ET | 5155 | 56.93 |
| 11:54 ET | 1300 | 56.915 |
| 11:56 ET | 2048 | 56.94 |
| 11:58 ET | 1873 | 56.95 |
| 12:00 ET | 13274 | 56.97 |
| 12:02 ET | 6182 | 57.03 |
| 12:03 ET | 12383 | 57.04 |
| 12:05 ET | 3800 | 57.055 |
| 12:07 ET | 3509 | 57.035 |
| 12:09 ET | 4448 | 57.061 |
| 12:12 ET | 300 | 57.08 |
| 12:14 ET | 10693 | 57.09 |
| 12:16 ET | 1300 | 57.08 |
| 12:18 ET | 9080 | 57.11 |
| 12:20 ET | 1201 | 57.1 |
| 12:21 ET | 2614 | 57.05 |
| 12:23 ET | 1521 | 57.06 |
| 12:25 ET | 746 | 57.095 |
| 12:27 ET | 3094 | 57.115 |
| 12:30 ET | 2514 | 57.12 |
| 12:32 ET | 7964 | 57.16 |
| 12:34 ET | 820 | 57.1905 |
| 12:36 ET | 865 | 57.195 |
| 12:38 ET | 1396 | 57.21 |
| 12:39 ET | 2415 | 57.21 |
| 12:41 ET | 1607 | 57.22 |
| 12:43 ET | 4617 | 57.19 |
| 12:45 ET | 7288 | 57.14 |
| 12:48 ET | 1000 | 57.1 |
| 12:50 ET | 4341 | 57.145 |
| 12:52 ET | 2285 | 57.15 |
| 12:54 ET | 3850 | 57.11 |
| 12:56 ET | 2167 | 57.15 |
| 12:57 ET | 2489 | 57.07 |
| 12:59 ET | 2328 | 57.125 |
| 01:01 ET | 500 | 57.16 |
| 01:03 ET | 1200 | 57.195 |
| 01:06 ET | 2827 | 57.12 |
| 01:08 ET | 1253 | 57.14 |
| 01:10 ET | 6514 | 57.14 |
| 01:12 ET | 2900 | 57.08 |
| 01:14 ET | 10057 | 57.11 |
| 01:15 ET | 200 | 57.14 |
| 01:17 ET | 600 | 57.11 |
| 01:19 ET | 2492 | 57.11 |
| 01:21 ET | 1476 | 57.14 |
| 01:24 ET | 800 | 57.14 |
| 01:26 ET | 1849 | 57.11 |
| 01:28 ET | 1031 | 57.13 |
| 01:30 ET | 300 | 57.13 |
| 01:32 ET | 1100 | 57.155 |
| 01:33 ET | 900 | 57.13 |
| 01:35 ET | 3727 | 57.095 |
| 01:37 ET | 4723 | 57.15 |
| 01:39 ET | 1725 | 57.095 |
| 01:42 ET | 2032 | 57.12 |
| 01:44 ET | 3529 | 57.165 |
| 01:46 ET | 542 | 57.18 |
| 01:48 ET | 1300 | 57.165 |
| 01:50 ET | 2755 | 57.18 |
| 01:51 ET | 1269 | 57.17 |
| 01:53 ET | 2138 | 57.17 |
| 01:55 ET | 1676 | 57.17 |
| 01:57 ET | 1660 | 57.1707 |
| 02:00 ET | 842 | 57.17 |
| 02:02 ET | 2807 | 57.18 |
| 02:04 ET | 815 | 57.175 |
| 02:06 ET | 1217 | 57.16 |
| 02:08 ET | 1100 | 57.17 |
| 02:09 ET | 1232 | 57.175 |
| 02:11 ET | 1022 | 57.18 |
| 02:13 ET | 3091 | 57.14 |
| 02:15 ET | 1114 | 57.115 |
| 02:18 ET | 3936 | 57.14 |
| 02:20 ET | 400 | 57.125 |
| 02:22 ET | 3144 | 57.085 |
| 02:24 ET | 3409 | 57.12 |
| 02:26 ET | 2704 | 57.12 |
| 02:27 ET | 2418 | 57.15 |
| 02:29 ET | 1994 | 57.15 |
| 02:31 ET | 900 | 57.16 |
| 02:33 ET | 2406 | 57.16 |
| 02:36 ET | 1411 | 57.17 |
| 02:38 ET | 3545 | 57.12 |
| 02:40 ET | 1601 | 57.13 |
| 02:42 ET | 1724 | 57.12 |
| 02:44 ET | 2300 | 57.09 |
| 02:45 ET | 2890 | 57.115 |
| 02:47 ET | 1936 | 57.12 |
| 02:49 ET | 300 | 57.12 |
| 02:51 ET | 1507 | 57.111 |
| 02:54 ET | 1598 | 57.135 |
| 02:56 ET | 3305 | 57.1434 |
| 02:58 ET | 1300 | 57.14 |
| 03:00 ET | 4348 | 57.08 |
| 03:02 ET | 3099 | 57.05 |
| 03:03 ET | 743 | 57.02 |
| 03:05 ET | 4667 | 57.05 |
| 03:07 ET | 2324 | 57.05 |
| 03:09 ET | 5833 | 57.08 |
| 03:12 ET | 1756 | 57.1 |
| 03:14 ET | 2416 | 57.09 |
| 03:16 ET | 989 | 57.09 |
| 03:18 ET | 1491 | 57.1 |
| 03:20 ET | 2040 | 57.11 |
| 03:21 ET | 3863 | 57.11 |
| 03:23 ET | 2304 | 57.135 |
| 03:25 ET | 9942 | 57.195 |
| 03:27 ET | 3173 | 57.18 |
| 03:30 ET | 3123 | 57.21 |
| 03:32 ET | 6088 | 57.18 |
| 03:34 ET | 1641 | 57.175 |
| 03:36 ET | 2606 | 57.18 |
| 03:38 ET | 5175 | 57.17 |
| 03:39 ET | 3903 | 57.12 |
| 03:41 ET | 13815 | 57.21 |
| 03:43 ET | 9563 | 57.17 |
| 03:45 ET | 5877 | 57.19 |
| 03:48 ET | 4824 | 57.215 |
| 03:50 ET | 4538 | 57.211 |
| 03:52 ET | 9387 | 57.21 |
| 03:54 ET | 17074 | 57.205 |
| 03:56 ET | 38058 | 57.16 |
| 03:57 ET | 63086 | 57.17 |
| 03:59 ET | 71946 | 57.1 |
May 14, 2024
Incyte to Highlight Data From its Oncology Portfolio at the 2024 ASCO Annual Meeting and EHA2024 Congress, from 5:00PM ET on Tuesday May 14, 2024 by Dow Jones
5:00PM ET on Tuesday May 14, 2024 by Dow Jones
May 13, 2024
DJ Incyte Buyback Seen Luring Value Investors -- Market Talk, from 3:06PM ET on Monday May 13, 2024 by Dow Jones
3:06PM ET on Monday May 13, 2024 by Dow JonesDJ Incyte Shares Rally on $2 Billion Buyback Plans, from 10:05AM ET on Monday May 13, 2024 by Dow Jones
10:05AM ET on Monday May 13, 2024 by Dow JonesDJ Incyte Up Over 9%, on Pace for Largest Percent Increase Since August 2017 -- Data Talk, from 9:52AM ET on Monday May 13, 2024 by Dow Jones
9:52AM ET on Monday May 13, 2024 by Dow JonesDJ Incyte Stock Jumps on 'Dutch Auction' Buyback Plan. How It Works. -- Barrons.com, from 9:14AM ET on Monday May 13, 2024 by Dow Jones
9:14AM ET on Monday May 13, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Incyte Corp | 12.8B | 17.3x | +39.11% |
Charles River Laboratories International Inc | 11.6B | 26.0x | +15.57% |
United Therapeutics Corp | 12.1B | 13.0x | +8.22% |
Biomarin Pharmaceutical Inc | 14.6B | 73.4x | --- |
Exact Sciences Corp | 9.6B | -38.0x | --- |
Medpace Holdings Inc | 12.2B | 40.1x | +35.10% |
Company Information
Incyte Corporation is a biopharmaceutical company, which is focused on the discovery, development, and commercialization of therapeutics. The Company also conducts clinical development and commercial operations from its European headquarters in Morges, Switzerland and its other offices across Europe, as well as its Japanese office in Tokyo and its Canadian headquarters in Montreal. It operates in two therapeutic areas, One therapeutic area is Hematology/Oncology, which is comprised of Myeloproliferative Neoplasms and Graft-Versus-Host Disease, as well as solid tumors and hematologic malignancies. Its other therapeutic area is Inflammation and Autoimmunity, which includes its Dermatology commercial franchise. Its hematology and oncology franchise are comprised of four products, which are JAKAFI (ruxolitinib), MONJUVI (tafasitamab-cxix)/MINJUVI (tafasitamab), PEMAZYRE (pemigatinib), ICLUSIG (ponatinib), and ZYNYZ (retifanlimab-dlwr), as well as numerous clinical development programs.
Contact Information
- Headquarters
- 1801 Augustine Cut-OffWILMINGTON, DE, United States 19803
- Phone
- 302-498-6700
- Fax
- 302-636-5454
Executives
- Chairman of the Board, President, Chief Executive Officer
- Herve Hoppenot
- Chief Financial Officer, Executive Vice President
- Christiana Stamoulis
- Executive Vice President, Chief Scientific Officer
- Dashyant Dhanak
- Executive Vice President, General Manager, Europe
- Jonathan Dickinson
- Executive Vice President - Human Resources
- Paula Swain
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $12.8B |
|---|---|
Revenue (TTM) | $3.8B |
Shares Outstanding | 224.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.74 |
EPS | $3.29 |
Book Value | $23.14 |
P/E Ratio | 17.3x |
Price/Sales (TTM) | 3.4 |
Price/Cash Flow (TTM) | 15.4x |
Operating Margin | 18.25% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
